UVM Neuroscience Graduate Program

In a new study from the University of Vermont, NGP faculty members Osama Harraz and Mark Nelson identified a possible therapeutic target in vascular dementia. The study further indicates that concurrent mineralocorticoid receptor blockers may aid in protecting against late-life cognitive decline in hypertensive patients treated with certain antihypertensive agents.

JCI - Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease 7Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester, United Kingdom.